Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients
- Status
- COMPLETED
- Phase
- N/A
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Part 2 Expansion of Oral Rigosertib in Combination With Azacitidine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
- Status
- COMPLETED
- Phase
- N/A
DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients
- Status
- UNKNOWN
- Phase
- N/A
Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine Therapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- NA
Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
- Status
- COMPLETED
- Phase
- PHASE2
GVAX vs. Placebo for MDS/AML After Allo HSCT
- Status
- TERMINATED
- Phase
- PHASE2
Unrelated Umbilical Cord Blood (UBC)Transplantation
- Status
- COMPLETED
- Phase
- NA